Document is current
Any future updates will be listed below
-
Authors
Hutchings, Hayley A. https://orcid.org/0000-0003-4155-1741
Lanyon, Kirsty https://orcid.org/0000-0002-4227-6852
Lister, Steven https://orcid.org/0000-0001-6899-007X
Alikhan, Raza https://orcid.org/0000-0001-8762-1149
Halcox, Julian https://orcid.org/0000-0001-6926-2947
Holland, Gail https://orcid.org/0000-0002-6924-2521
Hughes, Arfon
Jenkins, Rhys
Laing, Hamish https://orcid.org/0000-0002-5661-7937
Lobban, Trudie https://orcid.org/0000-0002-1655-0387
Owen, Diane
Pollock, Kevin G. https://orcid.org/0000-0001-5298-0504
Todd, Ceri
Wareham, Kathie
-
Funding
Funding for this research was provided by:
bristol-myers squibb foundation
- License Information
-
More Information
Article History
Received: 20 July 2021
Accepted: 26 July 2022
First Online: 12 August 2022
Declarations
:
: This protocol has received ethics approval from the London — Riverside Research Ethics Committee (20/PR/0479). All participants will provide written informed consent prior to taking part in the proposed study.
: Participants will provide written informed consent for their anonymised data and interview quotes where relevant to be used in any future publications.
: Hayley A. Hutchings leads this independent research which has received funding from Pfizer and Bristol Myers Squibb. Hamish Laing is an employee of the Swansea University who has received a grant for a value-based healthcare programme of work from Pfizer Ltd., which he leads and is supported to attend a meeting. Steven Lister is an employee of BMS who are funding the independent research and holds stock in BMS and Pfizer. Kevin Pollock is an employee of BMS who have provided funding for the research. Julian Halcox has received funding to their instruction from Pfizer and Bristol Myers Squibb since initial planning of this work and has received research grants to institution from Pfizer and Bristol Myers Squibb, personal consulting fees and payments for lectures from Pfizer and Bristol Myers Squibb, Bayer, and Boehringer Ingelheim, and financial support from Pfizer and Bristol Myers Squibb for attending meetings including travel costs paid to meeting organizers/travel companies. Gail Holland, Kirsty Lanyon, Arfon Hughes, Rhys Jenkins, Trudie Lobban, Diane Owen, Ceri Todd, and Kathie Wareham declare that they have no competing interests.
